XML 15 R4.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Operating expenses    
Research and development $ 5,653 $ 1,648
General and administrative 3,352 1,730
Total operating expenses 9,005 3,378
Loss from operations (9,005) (3,378)
Other income, net 5 30
Warrant inducement expense   (4,829)
Loss before income tax benefit (9,000) (8,177)
Income tax benefit (501)  
Net loss and comprehensive loss $ (8,499) $ (8,177)
Net loss per share, basic and diluted $ (0.57) $ (8.52)
Weighted-average common shares outstanding, basic and diluted 14,831,049 959,285